This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Buy These 5 Best Value Stocks Making the Most of P/B Ratio
by Kinjel Shah
The P/B ratio helps to identify low-priced stocks with high growth prospects. SSRM, KBH, PSFE, JD and PEB are some such stocks.
Are Investors Undervaluing Pebblebrook Hotel Trust (PEB) Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Why Investors Need to Take Advantage of These 2 Finance Stocks Now
by Zacks Equity Research
Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.
Zacks.com featured highlights include JD.com, EnerSys, AXIS Capital and Pebblebrook Hotel
by Zacks Equity Research
JD.com, EnerSys, AXIS Capital and Pebblebrook Hotel have been highlighted in this Screen of The Week article.
4 Top Value Stocks to Invest In as the Market Faces Volatility
by Sumit Singh
Value investing is essentially about selecting stocks that are cheap but fundamentally sound. JD, ENS, AXS & PEB boast a low P/CF ratio.
Is It Wise to Retain Host Hotels Stock in Your Portfolio Now?
by Zacks Equity Research
HST is well-poised to benefit from the improvement in the group business. However, macroeconomic uncertainty adds to its woes.
PEB or OHI: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
PEB vs. OHI: Which Stock Is the Better Value Option?
Pebblebrook Hotel (PEB) Just Reclaimed the 50-Day Moving Average
by Zacks Equity Research
Is it a good or bad thing when a stock surpasses resistance at the 50-day simple moving average?
Pebblebrook's (PEB) Same-Property Revenues Improve in July
by Zacks Equity Research
Pebblebrook's (PEB) July operating results witness a year-over-year increase in same-property revenues, driven by a rise in non-room revenues.
Down -9.91% in 4 Weeks, Here's Why You Should You Buy the Dip in Pebblebrook Hotel (PEB)
by Zacks Equity Research
Pebblebrook Hotel (PEB) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.
PEB vs. OHI: Which Stock Is the Better Value Option?
by Zacks Equity Research
PEB vs. OHI: Which Stock Is the Better Value Option?
Should Value Investors Buy Pebblebrook Hotel Trust (PEB) Stock?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Pebblebrook Hotel (PEB) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
by Zacks Equity Research
The headline numbers for Pebblebrook Hotel (PEB) give insight into how the company performed in the quarter ended June 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Pebblebrook Hotel (PEB) Q2 FFO Surpass Estimates
by Zacks Equity Research
Pebblebrook Hotel (PEB) delivered FFO and revenue surprises of 15% and 0.57%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
How to Find Strong Finance Stocks Slated for Positive Earnings Surprises
by Zacks Equity Research
Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.
Alpine Income (PINE) Q2 FFO and Revenues Beat Estimates
by Zacks Equity Research
Alpine Income (PINE) delivered FFO and revenue surprises of 10.26% and 3.22%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
How to Boost Your Portfolio with Top Finance Stocks Set to Beat Earnings
by Zacks Equity Research
Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.
Pebblebrook's (PEB) Same-Property Revenues Improve in May
by Zacks Equity Research
Pebblebrook's (PEB) May operating results witness a year-over-year increase in same-property revenues, driven by a rise in non-room revenues.
These 2 Finance Stocks Could Beat Earnings: Why They Should Be on Your Radar
by Zacks Equity Research
Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.
Pebblebrook's (PEB) Same-Property Revenues Decline Y/Y in April
by Zacks Equity Research
Pebblebrook's (PEB) April operating results saw a decline in same-property revenues. It has also provided updates on the completion of redevelopment projects.
Compared to Estimates, Pebblebrook Hotel (PEB) Q1 Earnings: A Look at Key Metrics
by Zacks Equity Research
Although the revenue and EPS for Pebblebrook Hotel (PEB) give a sense of how its business performed in the quarter ended March 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Why Investors Need to Take Advantage of These 2 Finance Stocks Now
by Zacks Equity Research
Investors looking for ways to find stocks that are set to beat quarterly earnings estimates should check out the Zacks Earnings ESP.
Why Investors Need to Take Advantage of These 2 Finance Stocks Now
by Zacks Equity Research
Investors looking for ways to find stocks that are set to beat quarterly earnings estimates should check out the Zacks Earnings ESP.
Pebblebrook's (PEB) February Operating Results Meet Expectations
by Zacks Equity Research
Pebblebrook's (PEB) operating results for February match its expectations on continued demand recovery in urban markets.
What Makes Pebblebrook Hotel (PEB) a New Buy Stock
by Zacks Equity Research
Pebblebrook Hotel (PEB) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).